EGFR and breast cancer: Malignant basal-like breast tumors represent approximately 15% of all diagnosed cases of breast cancer, have high proliferation rates, and exhibit high expression of basal cytokeratins and epidermal growth factor receptor (EGFR), along with low expression of the luminal A genetic signature.